Author:
Vanover Kimberly E.,Robbins-Weilert Doris,Wilbraham Darren G.,Mant Timothy G. K.,van Kammen Daniel P.,Davis Robert E.,Weiner David M.
Subject
Pharmacology (medical),Pharmacology
Reference7 articles.
1. Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R, 3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-HT2A receptor inverse agonist;Vanover;J Pharmacol Exp Ther,2006
2. Pharmacokinetics, tolerability, and safety of ACP-103 following single or multiple oral dose administration in healthy volunteers;Vanover;J Clin Pharmacol,2007
3. Influence of food on the bioavailability of drugs;Melander;Clin Pharmacokinet,1978
4. Clinical pharmacokinetics of quetiapine:an atypical antipsychotic;DeVane;Clin Pharmacokinet,2001
5. Effects of food, antacid, and dosage form on the pharmacokinetics and relative bioavailability of sertindole in healthy volunteers;Wong;Biopharm Drug Dispos,1997
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献